Icon Wealth Partners, LLC Bristol Myers Squibb CO Transaction History

Icon Wealth Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $228,389 - $251,537	-3,145 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$61.48 - $73.72 $193,354 - $231,849	3,145 New	3,145 $230,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $190,882 - $223,594	-3,226 Closed	0 $0
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $20,306 - $22,113	-328 Reduced 9.23%	3,226 $216,000
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $210,894 - $237,193	3,554 New	3,554 $224,000
Q3 2020 Oct 22, 2020	SELL	$57.43 - $63.64 $475,118 - $526,493	-8,273 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$54.82 - $64.09 $453,525 - $530,216	8,273 New	8,273 $486,000
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $2,677 - $2,960	-60 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $2,707 - $3,228	60 New	60 $3,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $1,766 - $1,992	-32 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $1,616 - $2,015	32 New	32 $2,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $1,917 - $2,207	-32 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $1,918 - $2,091	32	32 $2,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Icon Wealth Partners, LLC with notifications on news.